JM Financial’s record carries a clean audit trail and a recent return to profitability, but the shape of that profit and the events that reshaped the group demand attention. An ₹847 crore impairment at subsidiary JMFARC forced the parent to sell its entire 71.79% stake and exit the ARC business, though resolution progress has since driven partial reversals. SEBI imposed a debt-securities lead-manager ban that was settled with disgorgement and a three-month voluntary debarment, while RBI separately restricted and then lifted a ban on subsidiary JMFPL’s share financing. Contingent liabilities are dominated by a ₹1,044 crore standalone income-tax dispute and a Supreme Court-protected borrower group at JMFARC where loans remain classified as Standard despite interest not serviced for over 180 days. Dividends have grown faster than cumulative operating cash generation, with a 10-year CFO/(PAT−other income) of 0.43x, while QIP proceeds were funnelled into subsidiaries. Revenue recognition is a persistent audit focus due to complex, milestone-contingent investment banking fees, while receivables have ballooned and a prior MSME loan portfolio gain partially reversed. Intra-group lending and asset shuffling among subsidiaries has escalated sharply, with aggregate outstanding caps rising from ₹750 crore per entity to ₹1,500 crore, while a 2023 shareholder vote on two material subsidiaries drew 51.31% dissent from public institutions. The company has cycled through three statutory audit firms in five years, ending with a relatively smaller auditor.
Key findings
- A single distressed account triggered an ₹847 crore impairment, leading to ARC exit
Major- In FY2023-24, subsidiary JMFARC recognised a fair value loss and impairment provision of ₹846.86 crore on investments in multiple trusts and loans related to one large account/exposure. Consequent to JMFARC's net worth reduction, the parent took an impairment provision on its investment in JMFARC. The parent sold its entire 71.79% stake in JMFARC for ₹856 crore in FY2024-25, recognising a net loss on sale of ₹87.34 crore. In FY2025-26, the Private Markets segment profit grew to ₹541.76 crore primarily from reversal of impairment provision on resolution of NPA assets. - SEBI imposed a debt-securities lead-manager ban, settled with disgorgement and voluntary debarment
Major- SEBI barred JM Financial from taking new mandates as lead manager for public issues of debt securities via an interim order on March 7, 2024, extended by a confirmatory order on June 20, 2024 until March 31, 2025. On September 19, 2025, the company settled by paying ₹1.56 crore settlement and ₹1.22 crore disgorgement and accepted a three-month voluntary debarment. Separately, RBI directed subsidiary JMFPL to cease share financing on March 5, 2024 and lifted the restriction on October 18, 2024 after a special audit. - Contingent liabilities are dominated by a ₹1,044 crore income-tax dispute and Supreme Court-protected Standard loans
Major- JM Financial standalone disputed income tax demands stood at ₹1,044.00 crore in both FY2025-26 and FY2024-25, with the company stating it expects no significant liability to materialise. At subsidiary JMFARC, loans to one borrower group where interest has not been serviced for over 180 days continue to be classified as Standard assets under Supreme Court orders directing “No Coercive Action”. JMFARC holds a provision of ₹227.18 crore against these accounts as required under RBI NPA guidelines. - Dividends have grown faster than cumulative operating cash generation, with a 10-year CFO/(PAT−other income) of 0.43x
Major- Over the ten years to FY26, cumulative CFO of ₹2,908 crore covered only 0.43x of cumulative PAT less other income (₹7,518 crore − ₹784 crore). Total dividend per share rose from ₹0.20 in FY20 to ₹3.25 in FY26, with FY26 cash outflow of ₹310.81 crore representing a payout ratio of 25.86% of consolidated net profit. Of the ₹770 crore QIP raised in June 2020, ₹725.71 crore was utilised by March 2025 for investment in rights issues of subsidiaries. - Revenue recognition is a persistent audit focus, while receivables have ballooned and a prior loan portfolio gain partially reversed
Major- The auditor has flagged revenue recognition for investment banking services as a Key Audit Matter in every annual report from FY2018-19 through FY2025-26, citing significant management judgement in milestone triggers and success-linked fees. Receivable days rose from 54 in FY25 to 128 in FY26, a 137% year-on-year increase, while the Days Sales in Receivables Index reached 2.37. JMFPL assigned MSME loans of ₹462.27 crore in FY2024-25 and recognised a net gain of ₹18.32 crore, then recognised a loss of ₹6.37 crore on foreclosure from the same portfolio in FY2025-26, partially reversing the prior-year gain. - Intra-group lending caps rose to ₹1,500 crore per entity
Major- The aggregate outstanding cap for related-party transactions with JM Financial Services Limited rose from ₹750 crore to ₹1,500 crore proposed for FY2027-28, with actual outstanding reaching ₹1,500 crore during the prior approval period. In FY2024-25, the company acquired 48.96% of JMFCSL from INH Mauritius 1 for ₹1,460 crore, then sold its entire 71.79% stake in JMFARC to JMFCSL for ₹856 crore. At the August 2023 AGM, resolutions for material RPTs with JMFCSL and JMFARC each passed with only 57.40% in favour, with public institutions voting 51.31% against while promoters abstained. - Three statutory audit firms in five years
Major- Deloitte Haskins & Sells LLP resigned effective October 28, 2021 citing RBI rotation requirements and its internal policy on coverage of revenues and assets. BSR & Co. LLP was appointed to fill the casual vacancy and subsequently reappointed for five years, but resigned during FY2024-25. KKC & Associates LLP was appointed from the 39th AGM on August 6, 2024 for five consecutive years.
What to watch
- JMFARC property attachment appeal. JMFARC’s appeal before the PMLA Appellate Tribunal against the February 2024 property attachment order remains pending as of the FY2025-26 annual report.
- Bombay High Court tax appeals. Decisions on JMFSL’s appeals for AYs 2012-13 and 2013-14 regarding arbitrage business disallowances, and filing of appeal for AY 2014-15, with Order Giving Effect pending as of the FY2025-26 reporting period.
- Unbilled dues and past-due receivables. Realisation of unbilled dues of ₹94.79 crore as of March 31, 2026 and collection of trade receivables past due over 180 days, given the rising trend in both balances.
Bottom line: This is a disclosed and audited record with consistently unqualified opinions and a recent profit rebound driven by resolution of distressed assets. The risk sits in three places: the persistent gap between reported earnings and operating cash generation that has funded growing dividends, the opacity of subsidiary-level CARO findings that the consolidated auditor flags but never details, and the escalating scale of intra-group transactions that public institutional shareholders have repeatedly opposed. Read the receivables line and the contingent liabilities note with those dynamics in mind, and watch the August 2026 AGM votes and the JMFARC appeal.